Pular para o conteúdo principal

ETHNOS_APP

Início • Busca • Periódicos • Lista 0

Gabriel Sanfélix-Gimeno

Dados Biográficos

ID5540296
NOMEGabriel Sanfélix-Gimeno
PRENOMESGabriel
SOBRENOMESanfélix-Gimeno
ASSINATURASANFÉLIX-GIMENO G
VERIFICADONão
TOTAL DE OBRAS5
TOTAL DE CITAÇÕES0
TOTAL COMO AUTOR5
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO2010
ANO MAIS RECENTE DE PUBLICAÇÃO2025
ÍNDICE H0
  • Association of glucagon-like peptide-1 receptor agonists with acute pancreatitis and biliary disease in individuals with diabetes and obesity

    Open Access•Celia Robles Cabanillas, Isabel Hurtado et al.•ARTICLE•Gaceta Sanitaria•2025

    To evaluate the risk of acute pancreatitis and biliary disease in patients treated with glucagon-like peptide-1 receptor agonists (GLP-1 RA). Population-based, propensity-weighted, new user, active comparator design study including patients with diabetes and obesity initiating treatment with GLP-1 RA or the comparator group sodium-glucose cotransporter 2 inhibitors (SGLT-2i) in the region of Valencia from 2015 to 2021. In adjusted, per protocol m…

  • Group-based Trajectory Models to Assess Quality of INR Control and Its Association With Clinical Outcomes

    Open Access•Aníbal García-Sempere, Aníbal García‐Sempere et al.•ARTICLE•Medical Care•2020•Referências: 17

    BACKGROUND: The Time in Therapeutic Range (TTR) is the gold-standard measure used to assess the quality of oral anticoagulation with vitamin K antagonists. However, TTR is a static measure, and International Normalized Ratio (INR) control is a dynamic process. Group-based Trajectory Models (GBTM) can address this dynamic nature by classifying patients into different trajectories of INR control over time. OBJECTIVES: The objective of this study wa…

  • Did Hedis Get it Right? Evaluating the Quality of a Quality Measure

    Gabriel Sanfélix-Gimeno, Gabriel Sanfélix‐Gimeno et al.•ARTICLE•Medical Care•2014•Referências: 14

    BACKGROUND: As an example of the process that could be used to evaluate and optimize the performance of quality measures in routine practice, we evaluated whether the Healthcare Effectiveness Data and Information Set (HEDIS) measure assessing the "persistence of β-blocker treatment after a heart attack" correlates with post-myocardial infarction (MI) outcomes and whether or not there are alternative specifications of this construct which are bett…

  • Group-based Trajectory Models

    Jessica M Franklin, William H Shrank et al.•ARTICLE•Medical Care•2013•Referências: 13

    BACKGROUND: Classifying medication adherence is important for efficiently targeting adherence improvement interventions. The purpose of this study was to evaluate the use of a novel method, group-based trajectory models, for classifying patients by their long-term adherence. RESEARCH DESIGN: We identified patients who initiated a statin between June 1, 2006 and May 30, 2007 in prescription claims from CVS Caremark and evaluated adherence over the…

  • Development and validation of a population-based prediction scale for osteoporotic fracture in the region of Valencia, Spain

    Open Access•José Sanfélix‐Genovés, José Sanfélix-Genovés et al.•ARTICLE•BMC Public Health•2010

    The ESOSVAL-R study will establish a prediction scale for osteoporotic fracture in Spanish adult population. This scale not only will constitute a useful prognostic tool, but also it will allow identifying intervention thresholds to support treatment decision-making in the Valencia setting, based mainly on the information registered in the electronic clinical records

Sem obras proeminentes nesta página.

  • Development and validation of a population-based prediction scale for osteoporotic fracture in the region of Valencia, Spain

    Open Access•José Sanfélix‐Genovés, José Sanfélix-Genovés et al.•ARTICLE•BMC Public Health•2010

    The ESOSVAL-R study will establish a prediction scale for osteoporotic fracture in Spanish adult population. This scale not only will constitute a useful prognostic tool, but also it will allow identifying intervention thresholds to support treatment decision-making in the Valencia setting, based mainly on the information registered in the electronic clinical records

  • Group-based Trajectory Models

    Jessica M Franklin, William H Shrank et al.•ARTICLE•Medical Care•2013•Referências: 13

    BACKGROUND: Classifying medication adherence is important for efficiently targeting adherence improvement interventions. The purpose of this study was to evaluate the use of a novel method, group-based trajectory models, for classifying patients by their long-term adherence. RESEARCH DESIGN: We identified patients who initiated a statin between June 1, 2006 and May 30, 2007 in prescription claims from CVS Caremark and evaluated adherence over the…

  • Did Hedis Get it Right? Evaluating the Quality of a Quality Measure

    Gabriel Sanfélix-Gimeno, Gabriel Sanfélix‐Gimeno et al.•ARTICLE•Medical Care•2014•Referências: 14

    BACKGROUND: As an example of the process that could be used to evaluate and optimize the performance of quality measures in routine practice, we evaluated whether the Healthcare Effectiveness Data and Information Set (HEDIS) measure assessing the "persistence of β-blocker treatment after a heart attack" correlates with post-myocardial infarction (MI) outcomes and whether or not there are alternative specifications of this construct which are bett…

  • Group-based Trajectory Models to Assess Quality of INR Control and Its Association With Clinical Outcomes

    Open Access•Aníbal García-Sempere, Aníbal García‐Sempere et al.•ARTICLE•Medical Care•2020•Referências: 17

    BACKGROUND: The Time in Therapeutic Range (TTR) is the gold-standard measure used to assess the quality of oral anticoagulation with vitamin K antagonists. However, TTR is a static measure, and International Normalized Ratio (INR) control is a dynamic process. Group-based Trajectory Models (GBTM) can address this dynamic nature by classifying patients into different trajectories of INR control over time. OBJECTIVES: The objective of this study wa…

  • Association of glucagon-like peptide-1 receptor agonists with acute pancreatitis and biliary disease in individuals with diabetes and obesity

    Open Access•Celia Robles Cabanillas, Isabel Hurtado et al.•ARTICLE•Gaceta Sanitaria•2025

    To evaluate the risk of acute pancreatitis and biliary disease in patients treated with glucagon-like peptide-1 receptor agonists (GLP-1 RA). Population-based, propensity-weighted, new user, active comparator design study including patients with diabetes and obesity initiating treatment with GLP-1 RA or the comparator group sodium-glucose cotransporter 2 inhibitors (SGLT-2i) in the region of Valencia from 2015 to 2021. In adjusted, per protocol m…

Medicine (5 obras) · Internal Medicine (4 obras) · Atrial Fibrillation Management and Outcomes (2 obras) · Cohort (2 obras) · Computer Science (2 obras) · Emergency Medicine (2 obras) · Environmental health (2 obras) · Internal Medicine (2 obras) · Medication Adherence and Compliance (2 obras) · Population (2 obras)

Ethnos_APP • Projeto Open Source • Licença MIT • Frontend v2.0.0 • Privacidade e Cookies • Documentação da API: api.ethnos.app/docs • Código da API: GitHub • DOI: 10.5281/zenodo.17049435 • Código do Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae